News

RebrAIn Featured by ActuIA for Pioneering Supervised AI-Driven Deep Brain Stimulation Targeting

14 February 2021

ActuIA Features RebrAIn’s Innovations in Supervised AI-Driven Deep Brain Stimulation

We are excited to share that RebrAIn has been featured by ActuIA for our innovative work in neurosurgical targeting for Deep Brain Stimulation (DBS).

The article highlights our supervised AI-driven solutions that significantly improve patient outcomes for those with Parkinson’s Disease and Essential Tremor. Founded by Professor Emmanuel Cuny and Dr. Nejib Zemzemi, RebrAIn is transforming the landscape of neurosurgery with our precise and effective treatments.

Read the full article, “Focus on RebrAIn, the start-up that aims to revolutionize the surgical targeting of Deep Brain Stimulation”, in French on actuia.com here.

An English translation by Google is available here.

back to the news page

More news

MedTech Strategist Features RebrAIn’s Precision Targeting Solutions for Parkinson’s Disease

May 22, 2024

We are delighted to share that MedTech Strategist has featured RebrAIn in their latest issue.The article explores how our supervised AI-driven platform, OptimMRI, simplifies precision targeting for Deep Brain Stimulation (DBS) in Parkinson’s Disease. By enhancing...

Focused Ultrasound Foundation Highlights RebrAIn’s AI Innovations in Neurosurgery

May 9, 2024

We are excited to share that the Focused Ultrasound Foundation has featured RebrAIn for our pioneering use of artificial intelligence in brain targeting. The article details how our supervised AI-driven platform, Optim MRI, enhances precision and effectiveness in...

L’Usine Digitale Highlights RebrAIn’s €3.7 Million Funding for Supervised AI-Driven Neurosurgery

Mar 24, 2024

We are pleased to share that L'Usine Digitale has featured RebrAIn for securing €3.7 million to advance our supervised AI-driven software. This innovative platform is designed to simplify the work of neurosurgeons by enhancing the precision and efficiency of Deep...